{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T15:12:32Z","timestamp":1658329952436},"reference-count":26,"publisher":"Oxford University Press (OUP)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPIDSJ"],"DOI":"10.1093\/jpids\/piw080","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T04:06:57Z","timestamp":1483502817000},"page":"piw080","source":"Crossref","is-referenced-by-count":0,"title":["A Time to Save"],"prefix":"10.1093","author":[{"given":"Carol J.","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"key":"2017011617402673000_piw080v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(73)80606-7"},{"key":"2017011617402673000_piw080v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(73)80524-4"},{"key":"2017011617402673000_piw080v1.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1974.03240080040025"},{"key":"2017011617402673000_piw080v1.4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.143.2.258"},{"key":"2017011617402673000_piw080v1.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197604012941404"},{"key":"2017011617402673000_piw080v1.6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108703"},{"key":"2017011617402673000_piw080v1.7","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/7.4.458"},{"key":"2017011617402673000_piw080v1.8","first-page":"184","article-title":"Prevention of pneumococcal pneumonia by vaccination","volume":"89","author":"Austrian","year":"1976","journal-title":"Trans Assoc Am Physicians"},{"key":"2017011617402673000_piw080v1.9","first-page":"144","article-title":"Semi-synthetic vaccines composed of capsular polysaccharides of pathogenic bacteria covalently bound to proteins for the prevention of invasive diseases","volume":"33","author":"Schneerson","year":"1983","journal-title":"Prog Allergy"},{"key":"2017011617402673000_piw080v1.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198606263142603"},{"key":"2017011617402673000_piw080v1.11","first-page":"583","article-title":"Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients","volume":"73","author":"Tuppurainen","year":"1989","journal-title":"Obstet Gynecol"},{"key":"2017011617402673000_piw080v1.12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1542\/peds.90.5.775","article-title":"Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis","volume":"90","author":"American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn","year":"1992","journal-title":"Pediatrics"},{"key":"2017011617402673000_piw080v1.13","first-page":"1","volume-title":"American College of Obstetricians and Gynecologists. Group B streptococcal infections in pregnancy: ACOG\u2019s recommendations. ACOG Newsletter","volume":"37","year":"1993"},{"key":"2017011617402673000_piw080v1.14","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease: a public health perspective","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","journal-title":"MMWR Recomm Rep"},{"key":"2017011617402673000_piw080v1.15","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease: revised guidelines from CDC","volume":"51","author":"Schrag","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"2017011617402673000_piw080v1.16","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease\u2013revised guidelines from CDC, 2010","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2017011617402673000_piw080v1.17","unstructured":"Institute of Medicine. New Vaccine Development Establishing Priorities: Diseases of Importance in the United States . Washington, DC: National Academies Press, 1985."},{"key":"2017011617402673000_piw080v1.18","unstructured":"CDC. Active Bacterial Core Surveillance (ABCs) Report, Emerging Infections Program Network. Group B Streptococcus , 2014. Available at: http:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/gbs14.pdf. Accessed 26 August 2016."},{"key":"2017011617402673000_piw080v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00353-0"},{"key":"2017011617402673000_piw080v1.20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit549"},{"key":"2017011617402673000_piw080v1.21","doi-asserted-by":"publisher","DOI":"10.1086\/323350"},{"key":"2017011617402673000_piw080v1.22","doi-asserted-by":"publisher","DOI":"10.1086\/422756"},{"key":"2017011617402673000_piw080v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.10.019"},{"key":"2017011617402673000_piw080v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61651-6"},{"key":"2017011617402673000_piw080v1.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005384"},{"key":"2017011617402673000_piw080v1.26","unstructured":"Ecclesiastes 3:1\u20138, 3:22. The Holy Bible. New International Version. Grand Rapids: Zondervan Bible Publishers; 1973."}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T14:57:20Z","timestamp":1658329040000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article-lookup\/doi\/10.1093\/jpids\/piw080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":26,"alternative-id":["10.1093\/jpids\/piw080"],"URL":"https:\/\/doi.org\/10.1093\/jpids\/piw080","relation":{},"ISSN":["2048-7193","2048-7207"],"issn-type":[{"value":"2048-7193","type":"print"},{"value":"2048-7207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]}}}